TFO Wealth Partners’s Immunogen Inc IMGN Stock Holding History

TFO Wealth Partners’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13	Closed	-$245	–	1112
2023 Q3	$245	Buy	+13	New	+$216	﹤0.01%	731

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TFO Wealth Partners's IMGN Position: Q4 2023 in Review

TFO Wealth Partners sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 13 shares — an estimated $245 sold.

TFO Wealth Partners first reported a position in IMGN in Q3 2023 and held it in 1 quarter. The position peaked at $245 in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

TFO Wealth Partners reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
TFO Wealth Partners sold 13 Immunogen Inc shares in Q4 2023, an estimated $245.
TFO Wealth Partners first reported a position in Immunogen Inc in Q3 2023 and held it in 1 quarter.
TFO Wealth Partners's Immunogen Inc position peaked at $245 in Q3 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on TFO Wealth Partners's 13F filing for Q4 2023, filed 12 Feb 2024.